Eli Lilly and Company (NYSE:LLY) said it intends to invest about $3 billion in China over the next ten years to expand manufacturing capacity for its experimental treatment for type 2 diabetes and ...

Eli Lilly and Company (NYSE:LLY) is one of the top stocks that will make you rich in 10 years. Reuters reported on March 2 that Eli Lilly and Company (NYSE:LLY) CFO ‌Lucas Montarce stated that the ...

Eli Lilly and Company (NYSE:LLY) is one of the best stocks for 20 years. On March 9, Eli Lilly released an updated statement following new implementation details from the Centers for Medicare and ...

Eli Lilly has officially launched Employer Connect, its direct-to-employer platform for its obesity medications, after ...

Right up front in its proxy filing with the SEC, Eli Lilly took care of justifying its $36.7 mill | With sales booming at Eli Lilly, the Indianapolis company has compensated CEO David Ricks with a $36 ...

Eli Lilly and Company (NYSE:LLY) is one of the best stocks that will always grow. Eli Lilly and Company (NYSE:LLY) announced on March 5 the launch of its Employer Connect platform, introducing new ...

Novo Nordisk A/S remains a Buy despite CagriSema setback; Eli Lilly and Company remains a Hold on valuation. Click for this ...

March 9 (Reuters) - Eli Lilly said on Monday a small number of basic Medicare drug plans may not follow the $50 per month cap on out-of-pocket costs for its weight-loss drugs, under the Medicare ...

Nevertheless, a high valuation and reduced free cash flow generation indicate elevated growth expectations along with considerable investment in future growth ...

Sales of Mounjaro rose 99% in 2025. Zepbound's sales rose an even more impressive 175%. Eli Lilly is the clear leader in the ...

SINGAPORE - Media OutReach Newswire - 12 March 2026 - Zuellig Pharma, a leading healthcare solutions company in Asia, today announced that it has acquired all rights, title, and interest in and to ...

Tim Coleman has held positions within information technology at Lilly in research and development, sales and marketing, manufacturing, and human resources.